| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Soteropoulos Paula is a Director at uniQure N.V. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $611K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc. | Director | Sale+OE | 599 | $80.11 | $47,985.89 | -100% | - | - | |
| Jun 13, 2024 | QURE Uniqure N.V. | Director | Sell | 2,220 | $5.14 | $11,410.80 | -9.9% | +4.2% | +192.2% | |
| Jun 16, 2023 | QURE Uniqure N.V. | Director | Sell | 2,275 | $18.99 | $43,202.25 | -9.2% | -60.6% | -74.9% | |
| Feb 27, 2023 | QURE Uniqure N.V. | Director | Sell | 384 | $19.97 | $7,668.48 | -2.3% | -8.4% | -67.9% | |
| Jan 18, 2023 | QURE Uniqure N.V. | Director | Sale+OE | 6,000 | $22.59 | $135,540.00 | -26.8% | -12.7% | -75.0% | |
| Dec 14, 2022 | QURE Uniqure N.V. | Director | Sale+OE | 6,800 | $23.44 | $159,384.00 | -17.2% | -15.4% | -65.6% | |
| Nov 29, 2022 | QURE Uniqure N.V. | Director | Sale+OE | 6,200 | $25.38 | $157,356.00 | -27.5% | -18.3% | -73.5% | |
| Feb 28, 2022 | QURE Uniqure N.V. | Director | Sell | 596 | $16.87 | $10,054.52 | -7.5% | -15.5% | +23.4% | |
| Mar 2, 2021 | QURE Uniqure N.V. | Director | Sell | 504 | $37.60 | $18,950.40 | -7.3% | - | - | |
| Feb 5, 2020 | QURE Uniqure N.V. | Director | Sell | 2,122 | $60.95 | $129,331.66 | -27.2% | - | - |